Search Results - "Löhr, H F"

Refine Results
  1. 1

    Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase by van Nunen, A B, Hansen, B E, Suh, D J, Löhr, H F, Chemello, L, Fontaine, H, Heathcote, J, Song, B C, Janssen, H L A, de Man, R A, Schalm, S W

    Published in Gut (01-03-2003)
    “…Background and aims: Interferon (IFN) induced hepatitis B e antigen (HBeAg) seroconversion is durable in 80–90% of chronic hepatitis B patients. Preliminary…”
    Get full text
    Journal Article
  2. 2

    Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis by DIENES, H. P, LOHSE, A. W, GERKEN, G, SCHIRMACHER, P, GALLATI, H, LÖHR, H. F, MEYER ZUM BÜSCHENFELDE, K. H

    “…Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are chronic autoimmune-mediated diseases of the biliary tree, resulting in a loss of…”
    Get full text
    Journal Article
  3. 3

    HLA-DRB11301 AND 1302 protect against chronic hepatitis B by Höhler, Thomas, Gerken, Guido, Notghi, Arman, Lubjuhn, Roswitha, Taheri, Homa, Protzer, Ulrike, Löhr, Hans F., Schneider, Peter M., Meyer zum Büschenfelde, Karl-H., Rittner, Christian

    Published in Journal of hepatology (01-03-1997)
    “…Background/Aims: The outcome of acute hepatitis B infection may be influenced by host factors like the major histocompatibility complex (MHC). We have…”
    Get full text
    Journal Article
  4. 4

    Regulation of the neutralizing anti‐hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection by BÖCHER, W. O., HERZOG‐HAUFF, S., HERR, W., HEERMANN, K., GERKEN, G., MEYER ZUM BÜSCHENFELDE, K.‐H., LÖHR, H. F.

    Published in Clinical and experimental immunology (01-07-1996)
    “…Antibodies directed to the HBs antigen indicate viral clearance and the development of life‐long immunity in patients that recovered from HBV infection. In HBs…”
    Get full text
    Journal Article
  5. 5

    Low Frequency of Cytotoxic Liver-Infiltrating T Lymphocytes Specific for Endogenous Processed Surface and Core Proteins in Chronic Hepatitis B by Löhr, H. F., Gerken, G., Schlicht, H.-J., zum Büschenfelde, K.-H. Meyer, Fleischer, B.

    Published in The Journal of infectious diseases (01-11-1993)
    “…To investigate the role of hepatitis Bvirus (HBV)-specific CD8+ T cells in chronic hepatitis B, the lytic activity of peripheral blood mononuclear cells (PBMC)…”
    Get full text
    Journal Article
  6. 6

    Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B – restoration by exogenous interleukin‐12 by LÖHR, H. F., PINGEL, S., BÖCHER, W. O., BERNHARD, H., HERZOG‐HAUFF, S., ROSE‐JOHN, S.

    Published in Clinical and experimental immunology (01-10-2002)
    “…SUMMARY Insufficient stimulatory capacities of autologous dendritic cells (DC) may contribute in part to impaired T cell stimulation and therefore viral…”
    Get full text
    Journal Article
  7. 7

    Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen by Rahman, Fareed, Dahmen, Anja, Herzog‐Hauff, Sabine, Böcher, Wulf O., Galle, Peter R., Löhr, Hanns F.

    Published in Hepatology (Baltimore, Md.) (01-02-2000)
    “…The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing…”
    Get full text
    Journal Article
  8. 8

    HBV‐specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro‐ and anti‐inflammatory cytokines by SCHLAAK, J. F, TULLY, G, LÖHR, H. F, GERKEN, G, BÜSCHENFELDE, K.-H. M. Z

    Published in Clinical and experimental immunology (01-03-1999)
    “…The aim of this study was to examine the immunomodulating effects of rhIL‐12 on the immune response induced by hepatitis B virus (HBV) antigens in clinical…”
    Get full text
    Journal Article
  9. 9

    Individual and Common Antigen‐Recognition Sites of Liver‐Derived T Cells in Patients with Autoimmune Hepatitis by Löhr, H. F., Pingel, S., Weyer, S., Fritz, T., Galle, P. R.

    Published in Scandinavian journal of immunology (01-04-2003)
    “…Autoimmune hepatitis (AIH) is characterized by dense T‐cell infiltrations in the liver tissue, but little is known how T cells influence the pathogenesis. To…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C by Hempel, Gerd, Galle, Peter R., Löhr, Hanns F.

    Published in Journal of medical virology (01-07-2001)
    “…This study aimed to characterise the immune mechanisms relevant to viral clearance in interferon (IFN)‐α‐treated chronic hepatitis C virus (HCV) infection…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome by Löhr, Hanns F., Gerken, Guido, Roth, Michael, Weyer, Sandra, Schalaak, Jörg F., Büschenfelder, Karl-Hermann Meyer zum

    Published in Journal of hepatology (01-10-1998)
    “…Background/Aims: To study whether the host's immune response determines viral clearance in chronic hepatitis C, virological markers and antigen-specific T cell…”
    Get full text
    Journal Article
  14. 14

    Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients by Lohse, A W, Gerken, G, Mohr, H, Löhr, H F, Treichel, U, Dienes, H P, Meyer zum Büschenfelde, K H

    Published in Zeitschrift für Gastroenterologie (01-09-1995)
    “…An etiopathological link between hepatitis virus infection and autoimmune liver disease, in particular autoimmune hepatitis has been suggested. In some…”
    Get more information
    Journal Article
  15. 15

    The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response by Schlaak, Jörg F, Tully, Glenn, Löhr, Hanns F, Gerken, Guido, Büschenfelde, Karl-Hermann Meyer zum

    Published in Journal of hepatology (01-03-1999)
    “…Background/Aims: The aim of this study was to examine the influence of the viral load on costimulatory effects of rhIL-12 on the hepatitis B virus…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Antigen-independent in vitro expansion of T cells does not affect the T cell receptor Vβ repertoire by ARENZ, M, HERZOG-HAUFF, S, MEYER ZUM BÜSCHENFELDE, K.-H, LÖHR, H. F

    “…Analysis of the variable chains (V alpha/V beta) of the specific T cell receptor (TCR) of organ-infiltrating T cells may provide further insights into the…”
    Get full text
    Conference Proceeding Journal Article
  18. 18
  19. 19

    HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-alpha by Löhr, H F, Goergen, B, Meyer zum Büschenfelde, K H, Gerken, G

    Published in Journal of medical virology (01-08-1995)
    “…Recently, it was demonstrated in chronic hepatitis C that the release of IgG and IgM anti-HCV antibodies by mononuclear cells (PBMCs) correlated with…”
    Get more information
    Journal Article
  20. 20

    Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells by Schlaak, Jörg F., Pitz, Tanja, Löhr, Hanns F., zum Büschenfelde, Karl-Hermann Meyer, Gerken, Guido

    Published in Journal of medical virology (01-10-1998)
    “…The aim of this study was to examine the possible immunomodulating effects of rhIL‐12 on the immune response induced by different hepatitis C virus (HCV)…”
    Get full text
    Journal Article